Giuseppe Ciaramella

Giuseppe Ciaramella

President at BEAM THERAPEUTICS INC.

Net worth: 6 M $ as of 2024-03-30

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Currently, Giuseppe Ciaramella holds the position of President & Chief Scientific Officer at Beam Therapeutics, Inc. He is also Member of Infectious Diseases Society of America and Member of American Society of Gene Therapy. In the past Dr. Ciaramella occupied the position of Chief Scientific Officer-Infectious Diseases at Moderna, Inc., Head-Biotherapeutics, Antivirals & Lead Discovery at Pfizer Group Ltd. and Vice President & Head-Collaborative Research at Boehringer Ingelheim Corp. Giuseppe Ciaramella received a doctorate from University College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-02 169,616 ( 0.21% ) 6 M $ 2024-03-30

Giuseppe Ciaramella active positions

CompaniesPositionStart
BEAM THERAPEUTICS INC. President 2020-01-23
Corporate Officer/Principal -
American Society of Gene Therapy Corporate Officer/Principal -
Founder -
All active positions of Giuseppe Ciaramella

Former positions of Giuseppe Ciaramella

CompaniesPositionEnd
MODERNA, INC. Chief Tech/Sci/R&D Officer 2018-01-31
Director/Board Member 2013-12-31
Corporate Officer/Principal 2010-12-31
Corporate Officer/Principal -
See the detail of Giuseppe Ciaramella's experience

Training of Giuseppe Ciaramella

University College London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Giuseppe Ciaramella's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BEAM THERAPEUTICS INC.

Health Technology

MODERNA, INC.

Health Technology

Private companies6

Health Technology

Health Technology

Commercial Services

American Society of Gene Therapy

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Giuseppe Ciaramella